GeneDx Holdings WGS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $94.92M-5.7% | $105.99M+23.0% | $96.96M+64.7% | $75.11M+31.6% | $100.69M+18.9% | ||
| $76.76M+29.1% | $66.29M+18.4% | $59.11M+0.9% | $60.44M+19.0% | $59.46M— | ||
| $260.27M+178% | $229.32M+427% | $192.58M+3,192% | $144.11M+2,109% | $93.68M+1,894% | ||
| $48.69M+9.7% | $49.11M+13.3% | $45.81M+10.4% | $46.01M+14.9% | $44.4M+7.6% | ||
| $270.63M+19.8% | $268.29M+35.5% | $237.58M+27.7% | $204.84M+26.3% | $225.82M+38.2% | ||
| $50.13M+37.8% | $45.69M+38.9% | $42.42M+34.9% | $40.12M+28.0% | $36.38M+16.2% | ||
| $1.64M— | —— | —— | —— | —— | ||
| $144.97M-6.5% | $168.48M+6.2% | $172.59M+6.5% | $176.69M+6.7% | $155.09M-8.3% | ||
| $506.3M+13.4% | $523.71M+24.9% | $493.9M+20.8% | $463.86M+19.2% | $446.43M+13.2% | ||
| $11.17M-29.6% | $2.46M-69.1% | $2.63M-70.8% | $3.52M-56.7% | $15.86M+67.3% | ||
| $0-100% | $4.54M+275% | $1.23M+2.0% | $1.22M+11.2% | $1.22M+52.5% | ||
| $87.64M+26.0% | $108.91M+98.7% | $87.62M+13.3% | $71.41M+4.6% | $69.54M+37.1% | ||
| $96.73M+86.8% | $48.18M-7.2% | $51.58M-0.9% | $51.68M-0.9% | $51.79M-1.0% | ||
| $220K-99.9% | $2.67M-98.5% | $201.64M-1.3% | $186.73M-4.3% | $189.03M+0.9% | ||
| 1B0.0% | 1B+49,999,900% | 1B0.0% | 1B0.0% | 1B0.0% | ||
| -$1.44B-5.7% | -$1.37B-1.6% | -$1.36B+0.2% | -$1.35B+0.1% | -$1.36B-2.9% | ||
| $254.12M-1.3% | $308.18M+25.7% | $292.26M+42.9% | $277.13M+42.8% | $257.41M+24.2% | ||
| $506.3M+13.4% | $523.71M+24.9% | $493.9M+20.8% | $463.86M+19.2% | $446.43M+13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can GeneDx Holdings cover its short-term obligations?
- Its current ratio is 3.09 — current assets exceed current liabilities.
- Where does GeneDx Holdings's balance sheet data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.